HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benita S Katzenellenbogen Selected Research

Glutathione (Reduced Glutathione)

9/2021Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benita S Katzenellenbogen Research Topics

Disease

74Breast Neoplasms (Breast Cancer)
04/2024 - 03/2002
43Neoplasms (Cancer)
01/2024 - 02/2004
12Neoplasm Metastasis (Metastasis)
01/2023 - 06/2005
6Triple Negative Breast Neoplasms
04/2023 - 01/2017
4Obesity
01/2023 - 08/2007
4Carcinogenesis
01/2023 - 11/2006
4Prostatic Neoplasms (Prostate Cancer)
01/2018 - 06/2005
3Inflammation (Inflammations)
09/2021 - 01/2015
3Body Weight (Weight, Body)
02/2016 - 11/2002
3Weight Gain
02/2016 - 11/2002
3Endometriosis
02/2016 - 12/2014
2Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 04/2005
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2021 - 12/2018
2Endometrial Neoplasms (Endometrial Cancer)
09/2021 - 07/2010
2Fatty Liver
09/2021 - 02/2016
2Insulin Resistance
12/2018 - 10/2016
2Infarction (Infarctions)
11/2018 - 01/2017
2Carcinoma (Carcinomatosis)
01/2017 - 04/2005
2Pelvic Pain
02/2016 - 01/2015
1Melanoma (Melanoma, Malignant)
09/2022
1Cardiovascular Diseases (Cardiovascular Disease)
09/2021
1Cognitive Dysfunction
12/2018
1Stroke (Strokes)
11/2018
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2018
1Neuroinflammatory Diseases
11/2018
1Atherosclerotic Plaque (Atheroma)
01/2018
1Hypertension (High Blood Pressure)
01/2018

Drug/Important Bio-Agent (IBA)

55Estrogen ReceptorsIBA
04/2024 - 06/2003
42Estrogens (Estrogen)FDA Link
04/2024 - 02/2003
23Hormones (Hormone)IBA
04/2023 - 02/2003
19Estradiol (Delestrogen)FDA LinkGeneric
04/2024 - 10/2003
19Estrogen Receptor alphaIBA
10/2022 - 07/2004
17Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2004
14Transcription Factors (Transcription Factor)IBA
01/2024 - 06/2003
12LigandsIBA
01/2021 - 02/2004
9TamoxifenFDA LinkGeneric
01/2024 - 02/2004
9Estrogen Receptor betaIBA
10/2022 - 07/2004
9Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021 - 02/2003
7Estrogen Receptor Modulators (Antiestrogen)IBA
06/2020 - 06/2003
7ChromatinIBA
09/2014 - 06/2007
5Fulvestrant (Faslodex)FDA Link
01/2022 - 02/2004
4Selective Estrogen Receptor Modulators (SERM)IBA
01/2024 - 02/2004
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 10/2016
4EnzymesIBA
01/2022 - 05/2005
4AndrogensIBA
01/2018 - 06/2005
4Raloxifene Hydrochloride (Evista)FDA Link
12/2008 - 02/2004
3Forkhead Transcription Factors (Forkhead Box Proteins)IBA
05/2024 - 09/2014
3Forkhead Box Protein M1IBA
01/2023 - 09/2014
3Progesterone Receptors (Progesterone Receptor)IBA
10/2022 - 02/2013
3Androgen Receptors (Androgen Receptor)IBA
01/2018 - 06/2005
3GenisteinIBA
12/2016 - 05/2008
3Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
09/2014 - 01/2011
3Phosphotransferases (Kinase)IBA
05/2014 - 09/2009
3SteroidsIBA
08/2006 - 04/2005
3Messenger RNA (mRNA)IBA
09/2005 - 03/2002
2Phenobarbital (Luminal)FDA Link
01/2023 - 06/2011
2CollagenIBA
09/2021 - 11/2015
2(S)- 5- (4- hydroxy- 3,5- dimethyl- phenyl)- indan- 1- olIBA
09/2021 - 11/2018
2SurvivinIBA
01/2021 - 06/2011
2Cadherins (E-Cadherin)IBA
01/2021 - 06/2005
2BESIBA
12/2016 - 11/2013
2EquolIBA
12/2016 - 11/2013
2daidzeinIBA
12/2016 - 11/2013
2LipidsIBA
02/2016 - 08/2007
2ProhibitinsIBA
02/2016 - 02/2008
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2009 - 08/2008
2Small Interfering RNA (siRNA)IBA
05/2008 - 06/2005
2Co-Repressor ProteinsIBA
02/2008 - 09/2005
1Caspase 3 (Caspase-3)IBA
04/2023
1CSK Tyrosine-Protein KinaseIBA
01/2023
1Melanins (Melanin)IBA
09/2022
1Dihydroxyphenylalanine (Dopa)IBA
09/2022
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
09/2022
1GlycogenIBA
01/2022
1HydrogelsIBA
01/2022
1Estrogen Receptor AntagonistsIBA
01/2022
1Lapatinib (GW572016)FDA Link
12/2021
1LeptinIBA
09/2021
1Fatty Acids (Saturated Fatty Acids)IBA
09/2021
1Glutathione (Reduced Glutathione)IBA
09/2021
1CystatinsIBA
01/2021
1RNA IsoformsIBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Exportin 1 ProteinIBA
08/2020
1selinexorIBA
08/2020
1LuciferasesIBA
06/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019
1xanthohumolIBA
12/2018
1FlavonoidsIBA
12/2018
1Angiotensin IIIBA
01/2018
1EstetrolIBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2017
1acrylic acid (acrylate)IBA
01/2017
1AntibodiesIBA
01/2017
1Neoplasm Antigens (Tumor Antigens)IBA
01/2017

Therapy/Procedure

32Therapeutics
04/2024 - 02/2003
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2021 - 05/2016
2Ovariectomy (Oophorectomy)
02/2016 - 11/2002
1Drug Tapering
04/2023